Denali Therapeutics
DNLI
#4389
Rank
ยฃ1.32 B
Marketcap
ยฃ9.13
Share price
-7.90%
Change (1 day)
-39.22%
Change (1 year)

Denali Therapeutics (DNLI) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ0.11 Billion

According to Denali Therapeutics 's latest financial reports the company's total liabilities are ยฃ0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Denali Therapeutics - Total liabilities on balance sheet (from 2016 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.11 B19.3%
2023-12-31ยฃ96.51 M-72.05%
2022-12-31ยฃ0.34 B5.5%
2021-12-31ยฃ0.32 B-1.66%
2020-12-31ยฃ0.33 B175.68%
2019-12-31ยฃ0.12 B33.12%
2018-12-31ยฃ90.7 M485.86%
2017-12-31ยฃ15.48 M-94.77%
2016-12-31ยฃ0.29 B738.41%
2015-12-31ยฃ35.3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.68 B 509.43% Jersey
ยฃ1.69 B 1,411.64%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.69 M-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ94.57 M-15.56%๐Ÿ‡ฌ๐Ÿ‡ง UK